Zoomex Expands Stock Perpetuals to Include TSLA and NVDA
Event summary
- Zoomex launched Stock Perpetuals for TSLA and NVDA, allowing traders to access major U.S. equities without a traditional brokerage account.
- The platform offers transparent mark-price, funding, and margin displays consistent with its crypto derivatives trading interface.
- Zoomex Stock Perpetuals currently span a growing list of household names, including UnitedHealth, General Electric, JPMorgan, and Gilead.
- Zoomex serves over 3 million users across 35+ countries and regions, offering access to 700+ trading pairs.
- The platform maintains regulatory registrations and licenses across multiple jurisdictions, including the U.S. MSB, Canada MSB, U.S. NFA, and Australia AUSTRAC.
The big picture
Zoomex's move to include TSLA and NVDA in its Stock Perpetuals offering is a strategic play to attract traders seeking seamless access to major U.S. equities without the friction of traditional brokerage accounts. This expansion aligns with the broader trend of crypto platforms diversifying into traditional financial instruments, potentially reshaping how traders access and manage their portfolios. The platform's focus on transparency and rule-based execution could set a new standard for derivatives trading, but its success will depend on regulatory acceptance and market adoption.
What we're watching
- Market Adoption
- How quickly Zoomex can attract traders to its Stock Perpetuals offering compared to traditional brokerage platforms.
- Regulatory Scrutiny
- Whether Zoomex's derivatives-first approach will face increased regulatory scrutiny as it expands into equities.
- Competitive Positioning
- The pace at which competitors in the crypto derivatives space introduce similar equity-linked products.
Related topics
